Microbot Medical Inc. Announces Growth Strategy Update

What Happened

• Microbot Medical Inc. filed a Form 8-K on September 28, 2026 (Item 7.01) to disclose a press release it disseminated on September 25, 2026 that updates certain growth strategies. The filing notes the press release is furnished as an exhibit and is incorporated by reference under the Regulation FD disclosure item.

Key Details

• Filing date: September 28, 2026 (Form 8-K).
• Press release date: September 25, 2026 — described as an update to the company’s growth strategies.
• The disclosure was made under Item 7.01 (Regulation FD) and the filing includes exhibits (press release and interactive cover page/XBRL).

Why It Matters

• The company used a Regulation FD disclosure to broadly communicate an update to its growth strategy; investors should treat the press release as the official source of those strategic details. This 8-K does not itself provide financial results or executive changes, so investors seeking specifics should review the attached press release and watch for follow-up filings or investor communications.